1. Genetic and immunologic factors in microvascular disease in Type I insulin-dependent diabetes;BODANSKY, H.H.; WOLF, E.; CUDWORTH, A.G.; DEAN, B.M.; NENEHAM, L.J.; BOTTAzzo, G.H.; MATTHEWS, J.A.; KURTZ, A.B.; KOHNER, E.M.;Diabetes,1982
2. Insulin-dependent diabetes mellitus: the initial lesion;CAHILL, G.R.; McDEVITT, H.O.;New England Journal ofMedicine,1981
3. Genetic susceptibility to the development of retinopathy in insulindependent diabetics;DORNAN, T.L.; TING, A.; MCPHERSON, C.K.; PECKARD, C.O.; MANN, J.I.; TURNER, R.C.; MORRIS, P.J.;Diabetes,1982
4. Treatment of diabetic necrobiosis with aspirin and dipyridamole;ELDON, A.; DIAZ, E.G.; NAPARSTEK, E.;New England Journal of Medicine,1978
5. HLA-D-related (DRW) antigens in juvenile diabetes mellitus;FARID, N.R.; SAMPSON, L.; NOEL, P.; BARNARD, J.M.; DAVIS, A.J.; HILLMAN, D.A.;Diabetes,1979